{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T18:56:19Z","timestamp":1772304979734,"version":"3.50.1"},"reference-count":86,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Stichting Overleven met Alvleesklierkanker","award":["-"],"award-info":[{"award-number":["-"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Non-human primate (NHP)-derived adenoviruses have formed a valuable alternative for the use of human adenoviruses in vaccine development and gene therapy strategies by virtue of the low seroprevalence of neutralizing immunity in the human population. The more recent use of several human adenoviruses as oncolytic agents has exhibited excellent safety profiles and firm evidence of clinical efficacy. This proffers the question whether NHP-derived adenoviruses could also be employed for viral oncolysis in human patients. While vaccine vectors are conventionally made as replication-defective vectors, in oncolytic applications replication-competent viruses are used. The data on NHP-derived adenoviral vectors obtained from vaccination studies can only partially support the suitability of NHP-derived adenoviruses for use in oncolytic virus therapy. In addition, the use of NHP-derived adenoviruses in humans might be received warily given the recent zoonotic infections with influenza viruses and coronaviruses. In this review, we discuss the similarities and differences between human- and NHP-derived adenoviruses in view of their use as oncolytic agents. These include their genome organization, receptor use, replication and cell lysis, modulation of the host\u2019s immune responses, as well as their pathogenicity in humans. Together, the data should facilitate a rational and data-supported decision on the suitability of NHP-derived adenoviruses for prospective use in oncolytic virus therapy.<\/jats:p>","DOI":"10.3390\/ijms21144821","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T11:47:46Z","timestamp":1594208866000},"page":"4821","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Non-Human Primate-Derived Adenoviruses for Future Use as Oncolytic Agents?"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1844-9247","authenticated-orcid":false,"given":"Selas T.F.","family":"Bots","sequence":"first","affiliation":[{"name":"Department of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9443-8377","authenticated-orcid":false,"given":"Rob C.","family":"Hoeben","sequence":"additional","affiliation":[{"name":"Department of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3181\/00379727-84-20714","article-title":"Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture","volume":"84","author":"Rowe","year":"1953","journal-title":"Exp. Boil. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1126\/science.137.3533.835","article-title":"The quest for human cancer viruses","volume":"137","author":"Trentin","year":"1962","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1073\/pnas.48.12.2051","article-title":"Oncogenic effects in hamsters of human adenovirus types 12 and 18","volume":"48","author":"Huebner","year":"1962","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/jgm.1094","article-title":"Gene therapy in The Netherlands: Highlights from the Low Countries","volume":"9","author":"Kaptein","year":"2007","journal-title":"J. Gene Med."},{"key":"ref_5","first-page":"a013003","article-title":"Adenovirus DNA Replication","volume":"5","author":"Hoeben","year":"2013","journal-title":"Cold Spring Harb. Perspect. Boil."},{"key":"ref_6","unstructured":"King, A.M.Q., Adams, M.J., Carstens, E.B., and Lefkowitz, E.J. (2012). Virus Taxonomy: Classification and Nomenclature of Viruses, Academic Press. Ninth Report of the International Committee on Taxonomy of Viruses."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1128\/JVI.00354-11","article-title":"Members of the adenovirus research community using the whole-genome sequence to characterize and name human adenoviruses","volume":"85","author":"Seto","year":"2011","journal-title":"J. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1128\/JVI.00491-11","article-title":"Members of the adenovirus research community toward an integrated human adenovirus designation system that utilizes molecular and serological data and serves both clinical and fundamental virology","volume":"85","author":"Aoki","year":"2011","journal-title":"J. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"10774","DOI":"10.1128\/JVI.00810-11","article-title":"Novel adenoviruses in wild primates: A high level of genetic diversity and evidence of zoonotic transmissions","volume":"85","author":"Wevers","year":"2011","journal-title":"J. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1007\/s00705-015-2575-z","article-title":"Taxonomy proposal for Old World monkey adenoviruses: Characterisation of several non-human, non-ape primate adenovirus lineages","volume":"160","author":"Podgorski","year":"2015","journal-title":"Arch. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12985-019-1248-z","article-title":"First evidence of a new simian adenovirus clustering with Human mastadenovirus F viruses","volume":"16","author":"Lange","year":"2019","journal-title":"Virol. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1093\/molbev\/msv090","article-title":"Multiple cross-species transmission events of human adenoviruses (HAdV) during hominine evolution","volume":"32","author":"Hoppe","year":"2015","journal-title":"Mol. Boil. Evol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1128\/JVI.77.15.8263-8271.2003","article-title":"Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: Efficient human cell infection and bypass of preexisting adenovirus immunity","volume":"77","author":"Vogels","year":"2003","journal-title":"J. Virol."},{"key":"ref_14","first-page":"351","article-title":"Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States","volume":"11","author":"Nwanegbo","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"10522","DOI":"10.1128\/JVI.00450-10","article-title":"Adenovirus-based vaccines: Comparison of vectors from three species of adenoviridae","volume":"84","author":"Chen","year":"2010","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jgm.1530","article-title":"Creation of a panel of vectors based on ape adenovirus isolates","volume":"13","author":"Roy","year":"2010","journal-title":"J. Gene Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.4049\/jimmunol.1202861","article-title":"Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization","volume":"190","author":"Quinn","year":"2013","journal-title":"J. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e1105429","DOI":"10.1080\/2162402X.2015.1105429","article-title":"Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma","volume":"5","author":"Capasso","year":"2015","journal-title":"OncoImmunology"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Kaj\u00e1n, G.L., Lipiec, A., Bartha, D., Allard, A., and Arnberg, N. (2018). A multigene typing system for human adenoviruses reveals a new genotype in a collection of Swedish clinical isolates. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0209038"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Dehghan, S., Seto, J., Liu, E.B., Ismail, A.M., Madupu, R., Heim, A., Jones, M.S., Dyer, D.W., Chodosh, J., and Seto, D. (2019). A zoonotic adenoviral human pathogen emerged through genomic recombination among human and nonhuman simian hosts. J. Virol., 93.","DOI":"10.1128\/JVI.00564-19"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1743-422X-7-303","article-title":"A novel adenovirus of Western lowland gorillas (Gorilla gorilla gorilla)","volume":"7","author":"Wevers","year":"2010","journal-title":"Virol. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1099\/jgv.0.000465","article-title":"Genome analysis of four Old World monkey adenoviruses supports the proposed species classification of primate adenoviruses and reveals signs of possible homologous recombination","volume":"97","author":"Podgorski","year":"2016","journal-title":"J. Gen. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.meegid.2018.08.020","article-title":"The possible origin of human adenovirus type 3: Evidence of natural genetic recombination between human and simian adenovirus","volume":"65","author":"Han","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1099\/jgv.0.000250","article-title":"Phylogenomic evidence for recombination of adenoviruses in wild gorillas","volume":"96","author":"Hoppe","year":"2015","journal-title":"J. Gen. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/s41598-018-37249-4","article-title":"Molecular evolution of human adenovirus (HAdV) species C","volume":"9","author":"Dhingra","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1038\/ncomms11473","article-title":"The extracellular interactome of the human adenovirus family reveals diverse strategies for immunomodulation","volume":"7","author":"Ramani","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1128\/JVI.02160-08","article-title":"Host immune responses to chronic adenovirus infections in human and nonhuman primates","volume":"83","author":"Calcedo","year":"2008","journal-title":"J. Virol."},{"key":"ref_28","first-page":"3348","article-title":"The presence of the adenovirus E3 region improves the oncolytic potency of conditionally replicative adenoviruses","volume":"8","author":"Suzuki","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0022-2836(81)90087-5","article-title":"Identification of common molecular subsequences","volume":"147","author":"Smith","year":"1981","journal-title":"J. Mol. Boil."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1093\/nar\/gkf436","article-title":"MAFFT: A novel method for rapid multiple sequence alignment based on fast Fourier transform","volume":"30","author":"Katoh","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/JVI.73.1.152-160.1999","article-title":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination","volume":"73","author":"Lole","year":"1999","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/rmv.612","article-title":"Adenovirus receptors: Implications for tropism, treatment and targeting","volume":"19","author":"Arnberg","year":"2009","journal-title":"Rev. Med. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2010","journal-title":"Nat. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.3892\/mmr.2016.5536","article-title":"Loss of coxsackie and adenovirus receptor expression in human colorectal cancer: A potential impact on the efficacy of adenovirus-mediated gene therapy in Chinese Han population","volume":"14","author":"Ma","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_35","first-page":"2485","article-title":"Expression of coxsackie and adenovirus receptor is correlated with inferior prognosis in liver cancer patients","volume":"17","author":"Yang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1099\/0022-1317-83-1-151","article-title":"Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor","volume":"83","author":"Cohen","year":"2002","journal-title":"J. Gen. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/sj.mt.6300078","article-title":"A CD46-binding chimpanzee adenovirus vector as a vaccine carrier","volume":"15","author":"Tatsis","year":"2007","journal-title":"Mol. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Abbink, P., Kirilova, M., Boyd, M., Mercado, N., Li, Z., Nityanandam, R., Nanayakkara, O., Peterson, R., LaRocca, R.A., and A\u00efd, M. (2018). Rapid cloning of novel rhesus adenoviral vaccine vectors. J. Virol., 92.","DOI":"10.1128\/JVI.01924-17"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"eaax3567","DOI":"10.1126\/sciadv.aax3567","article-title":"Human adenovirus type 26 uses sialic acid\u2013bearing glycans as a primary cell entry receptor","volume":"5","author":"Baker","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Lenman, A., Liaci, A.M., Liu, Y., \u00c5rdahl, C., Rajan, A., Nilsson, E., Bradford, W., Kaeshammer, L., Jones, M.S., and Fr\u00e4ngsmyr, L. (2015). Human adenovirus 52 uses sialic acid-containing glycoproteins and the coxsackie and adenovirus receptor for binding to target cells. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004657"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"16756","DOI":"10.1038\/srep16756","article-title":"Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice","volume":"5","author":"Dicks","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00430-019-00645-2","article-title":"Human adenovirus binding to host cell receptors: A structural view","volume":"209","author":"Stasiak","year":"2019","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"16031","DOI":"10.1038\/mto.2016.31","article-title":"Whole cell vaccination using immunogenic cell death by an oncolytic adenovirus is effective against a colorectal cancer model","volume":"3","author":"Yamano","year":"2016","journal-title":"Mol. Oncolytics"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.virol.2012.10.034","article-title":"A mouse mammary epithelial cell line permissive for highly efficient human adenovirus growth","volume":"435","author":"Wu","year":"2013","journal-title":"Virology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40425-018-0350-x","article-title":"Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells","volume":"6","author":"Lei","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"ref_46","unstructured":"Bots, S.T.F., Kemp, V., Lamfers, M.L.M., Van der Pluijm, G., and Hoeben, R.C. (2019, January 9\u201312). New non-human primate adenoviruses for use as oncolytic agents. Proceedings of the International Oncolytic Virus Conference, Rochester, MN, USA."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"26871","DOI":"10.18632\/oncotarget.15845","article-title":"A novel oncolytic adenovirus based on simian adenovirus serotype 24","volume":"8","author":"Cheng","year":"2017","journal-title":"Oncotarget"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.omto.2016.11.003","article-title":"Oncolytic group B adenovirus enadenotucirev mediates non-apoptotic cell death with membrane disruption and release of inflammatory mediators","volume":"4","author":"Dyer","year":"2016","journal-title":"Mol. Oncolytics"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3389\/fimmu.2019.00779","article-title":"Replicating adenovirus-SIV immunization of rhesus macaques induces mucosal dendritic cell activation and function leading to rectal immune responses","volume":"10","author":"Ko","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI78280","article-title":"Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling","volume":"125","author":"Quinn","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1016\/j.vaccine.2015.10.023","article-title":"Combination recombinant simian or chimpanzee adenoviral vectors for vaccine development","volume":"33","author":"Cheng","year":"2015","journal-title":"Vaccine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"115ra2","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"Colloca","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12936-017-1911-z","article-title":"New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model","volume":"16","author":"Limbach","year":"2017","journal-title":"Malar. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1016\/j.vaccine.2016.07.028","article-title":"Strain-dependent and distinctive T-cell responses to HIV antigens following immunisation of mice with differing chimpanzee adenovirus vaccine vectors","volume":"34","author":"Herath","year":"2016","journal-title":"Vaccine"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/CVI.00011-14","article-title":"Adenovirus type 4 and 7 vaccination or adenovirus type 4 respiratory infection elicits minimal cross-reactive antibody responses to nonhuman adenovirus vaccine vectors","volume":"21","author":"Paris","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00262-016-1831-8","article-title":"Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer","volume":"65","author":"Cappuccini","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1128\/JVI.02055-12","article-title":"Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+T cells induced by different adenovirus vectors","volume":"87","author":"Tan","year":"2012","journal-title":"J. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/imr.12657","article-title":"The function and dysfunction of memory CD8+T cells in tumor immunity","volume":"283","author":"Reading","year":"2018","journal-title":"Immunol. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"261ra153","DOI":"10.1126\/scitranslmed.3009185","article-title":"A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory","volume":"6","author":"Swadling","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_60","first-page":"1373","article-title":"Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors","volume":"87","author":"Provine","year":"2012","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/gt.2016.55","article-title":"T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates","volume":"23","author":"Rollier","year":"2016","journal-title":"Gene Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"11007","DOI":"10.1128\/JVI.05346-11","article-title":"Durable mucosal simian immunodeficiency virus-specific effector memory T lymphocyte responses elicited by recombinant adenovirus vectors in rhesus monkeys","volume":"85","author":"Li","year":"2011","journal-title":"J. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1128\/JVI.03771-13","article-title":"Adenovirus serotype 26 and 35 vectors induce simian immunodeficiency virus-specific T lymphocyte responses in foreskin in rhesus monkeys","volume":"88","author":"Balandya","year":"2014","journal-title":"J. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1038\/s41467-019-12980-2","article-title":"CXCR3 enables recruitment and site-specific bystander activation of memory CD8+ T cells","volume":"10","author":"Maurice","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41467-019-08534-1","article-title":"Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy","volume":"10","author":"Rosato","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e01120-17","DOI":"10.1128\/JVI.01120-17","article-title":"Vector order determines protection against pathogenic simian immunodeficiency virus infection in a triple-component vaccine by balancing CD4+ and CD8+ T-cell responses","volume":"91","author":"Sauermann","year":"2017","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1038\/s41467-019-13438-1","article-title":"CD4+ T cell help creates memory CD8+ T cells with innate and help-independent recall capacities","volume":"10","author":"Ahrends","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJMoa1410863","article-title":"Chimpanzee adenovirus vector ebola vaccine","volume":"376","author":"Ledgerwood","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ebiom.2018.02.025","article-title":"Correlates of protection against SIVmac251 infection in rhesus macaques immunized with chimpanzee-derived adenovirus vectors","volume":"31","author":"Tuyishime","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.4049\/jimmunol.1502137","article-title":"Vaccine induction of lymph node-resident simian immunodeficiency virus env-specific T follicular helper cells in rhesus macaques","volume":"196","author":"Demers","year":"2016","journal-title":"J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"eaaw4236","DOI":"10.1126\/scitranslmed.aaw4236","article-title":"A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials","volume":"11","author":"Ehrenberg","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/gt.2008.18","article-title":"Wild-type adenoviruses from groups A\u2013F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent","volume":"15","author":"Appledorn","year":"2008","journal-title":"Gene Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-0036-1584923","article-title":"Adenovirus: Epidemiology, global spread of novel serotypes, and advances in treatment and prevention","volume":"37","author":"Lynch","year":"2016","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcv.2018.04.012","article-title":"Molecular epidemiology of human adenovirus infections in Denmark, 2011\u20132016","volume":"104","author":"Barnadas","year":"2018","journal-title":"J. Clin. Virol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3201\/eid1807.111665","article-title":"Adenoviruses in fecal samples from asymptomatic rhesus macaques, United States","volume":"18","author":"Roy","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10329-016-0587-2","article-title":"A first report of non-invasive adenovirus detection in wild Assamese macaques in Thailand","volume":"58","author":"Sukmak","year":"2016","journal-title":"Primates"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"13410","DOI":"10.1038\/s41598-019-49829-z","article-title":"Adenovirus infection is associated with altered gut microbial communities in a non-human primate","volume":"9","author":"Wasimuddin","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Roy, S., Vandenberghe, L.H., Kryazhimskiy, S., Grant, R., Calcedo, R., Yuan, X., Keough, M., Sandhu, A., Wang, Q., and Medina-Jaszek, C.A. (2009). Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000503"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1080\/22221751.2019.1690953","article-title":"Are adenoviruses zoonotic? A systematic review of the evidence","volume":"8","author":"Borkenhagen","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1556\/004.2018.042","article-title":"Adenoviruses of the most ancient primate lineages support the theory on virus\u2212host co-evolution","volume":"66","author":"Podgorski","year":"2018","journal-title":"Acta Veter. Hung."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fpubh.2019.00305","article-title":"Infectious disease risk across the growing human-non human primate interface: A review of the evidence","volume":"7","author":"Devaux","year":"2019","journal-title":"Front. Public Health"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Folegatti, P., Bellamy, D., Roberts, R., Powlson, J., Edwards, N.J., Mair, C.F., Bowyer, G., Poulton, I., Mitton, C.H., and Green, N. (2019). Safety and immunogenicity of a novel recombinant simian adenovirus ChAdOx2 as a vectored vaccine. Vaccines, 7.","DOI":"10.3390\/vaccines7020040"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fimmu.2018.00335","article-title":"Seroprevalence of neutralizing antibodies against human adenovirus type-5 and chimpanzee adenovirus type-68 in cancer patients","volume":"9","author":"Zhao","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/2326-6066.CIR-18-0309","article-title":"Antibody-neutralized reovirus is effective in oncolytic virotherapy","volume":"6","author":"Berkeley","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jcb.22328","article-title":"The influence of innate and pre-existing immunity on adenovirus therapy","volume":"108","author":"Zaiss","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ympev.2016.11.013","article-title":"New adenoviruses from new primate hosts\u2014growing diversity reveals taxonomic weak points","volume":"107","author":"Celer","year":"2017","journal-title":"Mol. Phylogenet. Evol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/14\/4821\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:48:47Z","timestamp":1760176127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/14\/4821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,8]]},"references-count":86,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["ijms21144821"],"URL":"https:\/\/doi.org\/10.3390\/ijms21144821","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,8]]}}}